Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Victoria J. South is active.

Publication


Featured researches published by Victoria J. South.


Nature Genetics | 1999

A novel endothelial-derived lipase that modulates HDL metabolism.

Kevin J. Lynch; John A. Krawiec; Dawn Marchadier; Cyrille Maugeais; Kim Doan; Victoria J. South; Dilip Amin; Mark H. Perrone; Daniel J. Rader

High-density lipoprotein (HDL) cholesterol levels are inversely associated with risk of atherosclerotic cardiovascular disease. At least 50% of the variation in HDL cholesterol levels is genetically determined, but the genes responsible for variation in HDL levels have not been fully elucidated. Lipoprotein lipase (LPL) and hepatic lipase (HL), two members of the triacylglyerol (TG) lipase family, both influence HDL metabolism and the HL (LIPC) locus has been associated with variation in HDL cholesterol levels in humans. We describe here the cloning and in vivo functional analysis of a new member of the TG lipase family. In contrast to other family members, this new lipase is synthesized by endothelial cells in vitro and thus has been termed endothelial lipase (encoded by the LIPG gene). EL is expressed in vivo in organs including liver, lung, kidney and placenta, but not in skeletal muscle. In contrast to LPL and HL, EL has a lid of only 19 residues. EL has substantial phospholipase activity, but less triglyceride lipase activity. Overexpression of EL in mice reduced plasma concentrations of HDL cholesterol and its major protein apolipoprotein A-I. The endothelial expression, enzymatic profile and in vivo effects of EL suggest that it may have a role in lipoprotein metabolism and vascular biology.


Annals of the New York Academy of Sciences | 1991

Cloning, expression of the human substance K receptor, and analysis of its role in mitogenesis.

Curt Cyr; Victoria J. South; Alan Saltzman; Stephen Felder; George A. Ricca; Kay Huebnerf; Jakob Kagan; Carlo M. Croce; Joseph Schlessinger; Richard Kris

The primary strudure of the human substance K receptor was established from the sequences of complementary DNA clones isolated from a human jejunal complementary DNA library. It consists of 398 amino acids, including seven putative transmembrane regions. The gene for the human substance K receptor was localized to chromosome region 10p13-10q23, a region with frequent chromosomal abnormalities. The human substance K receptor was expressed in transfeded NIH-3T3 cells lacking endogenous substance K receptors, and Scatchard analysis of 125I labeled substance K binding indicates approximately 100,000 receptors/cell with a single dissociation constant of 12 nM. Covalent cross-linking experiments utilizing 125I-substanceK and three different chemical cross-linking reagents (disuccinimidyl suberate, disuccinimidyl tartrate, or 1-ethyl-3-(3dimethylaminopropyl)carbodiimide-HCI) demonstrate an apparent molecular weight of 45,000, consistent with little or no N-linked glycosylation. The binding of substance K to its receptor on transfeded cells led to a rapid increase in the produdion of total inositol phosphates and the release of Ca2� from internal stores. Growth of the cells transfeded with the human substance K receptor is stimulated by the addition of substance K to the medium to a level similar to 10% serum. Therefore, the human substance K receptor can function as a growth fador receptor when expressed in mouse 3T3 cells.


Archive | 1999

Compositions and Methods for Effecting the Levels of High Density Lipoprotein (HDL) Cholesterol and Apolipoprotein AI, Very Low Density Lipoprotein (VLDL) Cholesterol and Low Density Lipoprotein (LDL) Cholesterol

Kim-Anh Thi Doan; John A. Krawiec; Kevin J. Lynch; Dilip Amin; Victoria J. South; Dawn Marchadier; Cyrille Maugeais; Daniel J. Rader


Archive | 1995

Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same

Joseph Schlessinger; David Givol; Francoise Bellot; Richard M. Kris; George A. Ricca; Christopher Cheadle; Victoria J. South


Archive | 2000

Compositions and methods for effecting the levels of cholesterol

Kevin J. Lynch; Dilip Amin; Kim-Anh Thi Doan; Dawn Marchadier; Cyrille Maugeais; Daniel J. Rader; John A. Krawiec; Victoria J. South


Archive | 1994

Expression cloning of c-src SH3-domain binding proteins

George Searfoss; Yuri Ivashchenko; Victoria J. South; Stephen M. French; Christopher Cheadle; George A. Ricca


Archive | 1997

Polypeptides encoded by a human lipase-like gene, compositions and methods

Kim-Anh Thi Doan; John A. Krawiec; Kevin J. Lynch; Dilip Amin; Victoria J. South


Archive | 1997

Polypeptides llg de la famille des triacylglycerol lipases, compositions et procedes destines a l'utilisation de ceux-ci dans des hydrolyses enzymatiques, et therapies geniques et protidiques

Kim-Anh Thi Doan; John A. Krawiec; Kevin J. Lynch; Dilip Amin; Victoria J. South


Archive | 1997

Polipeptidos llg de la familia de las triacilglicerol lipasas, y composiciones y metodos para su uso en la hidrolisis enzimatica y terapias proteicas y genicas.

Dilip Amin; Kim-Anh Thi Doan; John A. Krawiec; Kevin J. Lynch; Victoria J. South


Archive | 1997

Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden From human lipase-like gen encoded polypeptide, as well as compositions and methods

Kim-Anh Thi Doan; John A. Krawiec; Kevin J. Lynch; Dilip Amin; Victoria J. South

Collaboration


Dive into the Victoria J. South's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cyrille Maugeais

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Daniel J. Rader

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Dawn Marchadier

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge